[1]徐晨曦.甲巯咪唑与丙硫氧嘧啶对甲亢患者甲状腺功能及肝功能指标的影响[J].医学信息,2022,35(08):147-149.[doi:10.3969/j.issn.1006-1959.2022.08.037]
　XU Chen-xi.Effect of Methimazole and Propylthiouracil on Thyroid Function and Liver Function in Patients with Hyperthyroidism[J].Medical Information,2022,35(08):147-149.[doi:10.3969/j.issn.1006-1959.2022.08.037]
点击复制

甲巯咪唑与丙硫氧嘧啶对甲亢患者甲状腺功能及肝功能指标的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年08期
页码:
147-149
栏目:
药物与临床
出版日期:
2022-04-15

文章信息/Info

Title:
Effect of Methimazole and Propylthiouracil on Thyroid Function and Liver Function in Patients with Hyperthyroidism
文章编号:
1006-1959（2022）08-0147-03
作者:
徐晨曦
（天津市蓟州区人民医院综合内科，天津 301900）
Author(s):
XU Chen-xi
(Department of General Medicine,Tianjin Jizhou District People’s Hospital,Tianjin 301900,China)
关键词:
甲亢; 甲巯咪唑; 丙硫氧嘧啶; 甲状腺功能; 肝功能
Keywords:
Hyperthyroidism; Methimazole; Propylthiouracil; Thyroid function; Liver function
分类号:
R581.1
DOI:
10.3969/j.issn.1006-1959.2022.08.037
文献标志码:
A
摘要:
目的 分析甲巯咪唑与丙硫氧嘧啶对甲亢患者甲状腺功能及肝功能指标的影响，为临床用药提供参考。方法 选取2020年3月-2021年3月收治的84例甲亢患者，按照随机数字表法分为甲巯咪唑组与丙硫氧嘧啶组，各42例，分别给予甲巯咪唑与丙硫氧嘧啶口服治疗。比较两组甲状腺功能指标[促甲状腺激素（TSH）、三碘甲腺原氨酸（FT3）、四碘甲腺原氨酸（FT4）]、肝功能指标[丙氨酸氨基转移酶（ALT）、天冬氨酸氨基转移酶（AST）、谷氨酰转肽酶（GGT）]、肝功能受损情况及不良反应。结果 两组FT3、FT4低于治疗前，TSH高于治疗前，且甲巯咪唑组FT3、FT4低于丙硫氧嘧啶组，TSH高于丙硫氧嘧啶组，差异有统计学意义（P＜0.05）；丙硫氧嘧啶组ALT、AST、GGT高于治疗前，且高于甲巯咪唑组，差异有统计学意义（P＜0.05）；甲巯咪唑组治疗前后ALT、AST、GGT比较，差异无统计学意义（P＞0.05）；甲巯咪唑组肝损伤率为4.76%，低于丙硫氧嘧啶组的19.05%，差异有统计学意义（P＜0.05）；两组不良反应总发生率比较，差异无统计学意义（P＞0.05）。结论 甲巯咪唑与丙硫氧嘧啶均可有效改善甲亢患者的甲状腺功能，前者效果更佳，且肝损伤毒性更小。
Abstract:
Objective To analyze the effect of methimazole and propylthiouracil on thyroid function and liver function indexes in patients with hyperthyroidism, and to provide reference for clinical medication.Methods A total of 84 patients with hyperthyroidism admitted to our hospital from March 2020 to March 2021 were selected and randomly divided into methimazole group and propylthiouracil group, with 42 cases in each group. The thyroid function indexes [thyroid stimulating hormone (TSH), triiodothyronine (FT3), tetraiodothyronine (FT4)], liver function indexes [alanine aminotransferase (ALT), aspartate aminotransferase (AST), glutamine transferase (GGT)], liver function damage and adverse reactions were compared between the two groups.Results The levels of FT3 and FT4 in the two groups were lower than those before treatment, the level of TSH was higher than that before treatment, the levels of FT3 and FT4 in the methimazole group were lower than those in the propylthiouracil group, the level of TSH was higher than that in the propylthiouracil group, the difference was statistically significant (P<0.05). The levels of ALT, AST and GGT in the propylthiouracil group were higher than those before treatment, and higher than those in the methimazole group, the difference was statistically significant (P<0.05). There was no significant difference in ALT, AST and GGT before and after treatment in methimazole group (P>0.05). The liver injury rate of methimazole group was 4.76%, which was lower than 19.05% of the propylthiouracil group, and the difference was statistically significant (P<0.05). There was no significant difference in the total incidence of adverse reactions between the two groups (P>0.05).Conclusion Both methimazole and propylthiouracil can effectively improve thyroid function in patients with hyperthyroidism. The former has better effect and less liver injury toxicity.

参考文献/References:

[1]段然,李静.甲状腺功能亢进症合并肝损害的鉴别诊断和处理[J].中国实用内科杂志,2018,38(10):971-973.[2]赵静,段莉莉,李超.甲巯咪唑对甲状腺功能亢进症患者甲状腺激素水平及肝功能的影响研究[J].临床和实验医学杂志,2021,20(3):282-286.[3]钱玉兰,高杰.我院甲巯咪唑和丙硫氧嘧啶致不良反应60例分析[J].中国药房,2016,27(20):2783-2785,2786.[4]吴夏茹.甲巯咪唑和丙硫氧嘧啶应用在甲状腺功能亢进症中的疗效及对肝功能的影响效果[J].吉林医学,2020,41(1):102-103.[5]潘春予,黄志荣,曾惠权.甲巯咪唑和丙硫氧嘧啶治疗甲亢的疗效及安全性研究[J].江西医药,2019,54(11):1385-1387.[6]Ross DS,Burch HB,Cooper DS,et al.2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis[J].Thyroid,2016,26(10):1343-1421.[7]刘敏,苏娜,秦舟,等.甲巯咪唑与丙硫氧嘧啶对甲状腺功能亢进患者肝功能影响的系统评价[J].医药导报,2019,38(7):940-946.[8]冯淼.丙硫氧嘧啶与甲巯咪唑在甲亢治疗中的临床疗效对比[J].基层医学论坛,2020,10(1):141-143.[9]钱晓娟,边德志,常丽,等.丙硫氧嘧啶与甲巯咪唑对甲状腺功能亢进症患者肝功能的影响[J].临床合理用药杂志,2018,11(33):75-76.[10]张铨胜,李钊.丙硫氧嘧啶与甲巯咪唑治疗甲状腺功能亢进症的临床效果比较[J].吉林医学,2020,11(9):2075-2079.[11]刘敏,苏娜,秦舟,等.甲巯咪唑和丙硫氧嘧啶对照治疗甲亢对血液系统影响的系统评价[J].中国药业,2018,27(19):22-27.[12]赖锦斌,邵光,罗毅平.丙硫氧嘧啶与甲巯咪唑对妊娠合并甲状腺功能亢进症患者肝功能、妊娠结局及新生儿甲状腺功能的影响[J].中国医药科学,2018,15(4):169-172.[13]刘红.甲巯咪唑与丙硫氧嘧啶治疗甲亢的疗效及对肝功能影响研究[J].中外医学研究,2018,16(11):113-114.[14]Yang H,Cong Y,Wu T,et al.Clinical efficacy of Yingliu mixture combined with metimazole for treating diffuse goitre with hyperthyroidism and its impact on related cytokines[J].Pharmaceutical Biology,2017,55(1):258.[15]白小岗,庞静,呼双琴,等.甲巯咪唑与丙硫氧嘧啶治疗甲亢的临床疗效和安全性对比研究[J].贵州医药,2017,41(9):945-946.[16]沈玉国,仝淼,王晓剑,等.甲巯咪唑和丙硫氧嘧啶对甲状腺功能亢进症患者的疗效及对肝功能的影响[J].医学综述,2016,9(5):230-234.[17]李玥,刘湘茹,胡德龙.甲巯咪唑与丙硫氧嘧啶治疗甲状腺机能亢进症的疗效比较[J].实用临床医学,2017,18(2):23-24,30.[18]陈慧,华文进.甲巯咪唑对甲亢患者甲状腺功能指标及肝功能指标的影响[J].贵州医药,2018,26(10):104-106.[19]许杰艺,黎亮,卢雄伟.比较甲巯咪唑与丙硫氧嘧啶对甲状腺功能亢进症患者肝功能的影响[J].河南外科学杂志,2017,23(6):99-100.[20]符宝林,符星.甲巯咪唑与丙硫氧嘧啶对甲状腺功能亢进患者肝功能影响的临床对照研究[J].药物评价研究,2017,40(4):545-548.

相似文献/References:

[1]苗艳茹.甲巯咪唑与糖皮质激素联合治疗甲状腺功能亢进症合并症的效果分析[J].医学信息,2018,31(05):136.[doi:10.3969/j.issn.1006-1959.2018.05.048]
　MIAO Yan-ru.Analysis of Effects of Methimazole and Glucocorticoids on Complications of Hyperthyroidism[J].Medical Information,2018,31(08):136.[doi:10.3969/j.issn.1006-1959.2018.05.048]
[2]康 凯,郑继伟,王 闰.糖皮质激素治疗甲亢伴浸润性突眼的疗效分析[J].医学信息,2018,31(08):103.[doi:10.3969/j.issn.1006-1959.2018.08.033]
　KANG Kai,ZHENG Ji-wei,WANG Run.Efficacy of Glucocorticoids in the Treatment of Hyperthyroidism with Infiltrating Exophthalmos[J].Medical Information,2018,31(08):103.[doi:10.3969/j.issn.1006-1959.2018.08.033]
[3]孙清林.放射性核素131I在甲亢治疗中的安全性与有效性分析[J].医学信息,2018,31(15):120.[doi:10.3969/j.issn.1006-1959.2018.15.038]
　SUN Qing-lin.Safety and Efficacy Analysis of Radionuclide 131I in the Treatment of Hyperthyroidism[J].Medical Information,2018,31(08):120.[doi:10.3969/j.issn.1006-1959.2018.15.038]
[4]蒋红梅.丙基硫氧嘧啶与甲巯咪唑治疗妊娠合并甲状腺功能亢进的疗效比较[J].医学信息,2019,32(05):154.[doi:10.3969/j.issn.1006-1959.2019.05.049]
　JIANG Hong-mei.Comparison of Propyl Thiouracil and Methimazole in the Treatment of Pregnancy with Hyperthyroidism[J].Medical Information,2019,32(08):154.[doi:10.3969/j.issn.1006-1959.2019.05.049]
[5]丹杨萍,谭丽艳,刘思聪,等.甲巯咪唑对Graves病患者血清FCRL3水平的影响[J].医学信息,2020,33(07):149.[doi:10.3969/j.issn.1006-1959.2020.07.048]
　DAN Yang-ping,TAN Li-yan,LIU Si-cong,et al.Effect of Methimazole on Serum FCRL3 Level in Patients with Graves Disease[J].Medical Information,2020,33(08):149.[doi:10.3969/j.issn.1006-1959.2020.07.048]
[6]姜丽莉,王 静,李振凤,等.甲巯咪唑对初诊Graves’病患者血清相关细胞因子及microRNAs水平的影响[J].医学信息,2020,33(08):101.[doi:10.3969/j.issn.1006-1959.2020.08.031]
　JIANG Li-li,WANG Jing,LI Zhen-feng,et al.Effects of Methimazole on Serum Levels of Cytokines and microRNAs in Newly Diagnosed Graves’ Disease Patients[J].Medical Information,2020,33(08):101.[doi:10.3969/j.issn.1006-1959.2020.08.031]
[7]张 晶.FT3、FT4、TSH与T3、T4联检评价甲状腺功能的临床意义[J].医学信息,2020,33(12):164.[doi:10.3969/j.issn.1006-1959.2020.11.054]
　ZHANG Jing.Clinical Significance of FT3,FT4,TSH and T3,T4 Joint Evaluation of Thyroid Function[J].Medical Information,2020,33(08):164.[doi:10.3969/j.issn.1006-1959.2020.11.054]
[8]魏月茹,康学东.康学东教授运用丹栀逍遥散合酸枣仁汤治疗肝郁阴虚型甲亢失眠临床经验[J].医学信息,2021,34(07):160.[doi:10.3969/j.issn.1006-1959.2021.07.045]
[9]王跃慧,李春彦.匹伐他汀与阿托伐他汀对缺血性卒中患者疗效及安全性的对比研究[J].医学信息,2022,35(08):150.[doi:10.3969/j.issn.1006-1959.2022.08.038]
　WANG Yue-hui,LI Chun-yan.A comparative Study of the Efficacy and Safety of Pivastatin and Atorvastatin in Patients with Ischemic Stroke[J].Medical Information,2022,35(08):150.[doi:10.3969/j.issn.1006-1959.2022.08.038]

更新日期/Last Update: 1900-01-01